Insulin Glargine (U-100) Cartridge Systems and Pens and Olaratumab Intravenous
Determining the interaction of Insulin Glargine (U-100) Cartridge Systems and Pens and Olaratumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: olaratumab
Brand name: Lartruvo
Synonyms: Olaratumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Glargine (U-100) Cartridge Systems and Pens-Oleptro
- Insulin Glargine (U-100) Cartridge Systems and Pens-Oleptro Oral
- Insulin Glargine (U-100) Cartridge Systems and Pens-Olmesartan
- Insulin Glargine (U-100) Cartridge Systems and Pens-Olmesartan and Hydrochlorothiazide
- Insulin Glargine (U-100) Cartridge Systems and Pens-Olmesartan Medoxomil
- Insulin Glargine (U-100) Cartridge Systems and Pens-Olmesartan Medoxomil and Hydrochlorothiazide
- Olaratumab Intravenous-Insulin Glargine (U-100) Vials
- Olaratumab Intravenous-Insulin Glargine (U-300) Pens
- Olaratumab Intravenous-Insulin glargine and lixisenatide
- Olaratumab Intravenous-Insulin glargine and lixisenatide Subcutaneous
- Olaratumab Intravenous-Insulin glargine, recombinant Subcutaneous
- Olaratumab Intravenous-Insulin glulisine